Day: August 8, 2025
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S.
TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) — O2Gold Inc. (NEX:OTGO.H) (“O2Gold” or the “Company”) is pleased to provide an additional update on its pending acquisition of a gold mining exploration property in Quebec through the purchase of all of the issued and outstanding shares of Quebec Aur Ltd. (the “Target”) pursuant to a share exchange agreement entered into by the Company with the Target and its shareholders dated April 15, 2024, as amended November 14, 2024 (the “Acquisition”).
The Company has upsized the hard dollar portion of its previously announced non-brokered private placement financing (the “Offering”) from 14 million units to 18 million units (the “Units”). Each Unit will continue to consist of one common share of the Company and one common...
FLINT Announces Transformational Recapitalization
Written by Customer Service on . Posted in Public Companies.
CALGARY, Alberta, Aug. 07, 2025 (GLOBE NEWSWIRE) — FLINT Corp. (“FLINT” or the “Company“) (TSX: FLNT) is pleased to announce a proposed recapitalization transaction (the “Recapitalization“) that will significantly reduce the Company’s debt and annual interest costs, simplify its capital structure and improve liquidity. The Recapitalization is the result of an extensive review process conducted by the Company’s board of directors (the “Board“), which culminated in FLINT entering into a definitive recapitalization support agreement (the “Support Agreement“) with its largest shareholder and primary lender, Canso Investment Counsel Ltd., in its capacity as portfolio manager for and on behalf of certain accounts that it manages (“Canso“). The Recapitalization...
BioVie Inc. Announces Pricing of $12 Million Public Offering
Written by Customer Service on . Posted in Public Companies.
CARSON CITY, Nev., Aug. 07, 2025 (GLOBE NEWSWIRE) — BioVie Inc. (NASDAQ: BIVI, BIVIW), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders, today announced the pricing of its underwritten public offering of 6,000,000 units, with each unit consisting of one share of common stock and one warrant (the “Warrants”) (or pre-funded units in lieu thereof, with each pre-funded unit consisting of one pre-funded warrant (the “Pre-Funded Warrants”) and one Warrant). Each unit is being sold to the public at a price of $2.00 per unit (and each pre-funded unit is being sold to the public at the public offering price of each unit less the $0.0001 per share nominal exercise price for each Pre-Funded...
Etoiles Capital Group Co., Ltd Announces Pricing of US$5.6 million Initial Public Offering
Written by Customer Service on . Posted in Public Companies.
HONG KONG, Aug. 08, 2025 (GLOBE NEWSWIRE) — Etoiles Capital Group Co., Ltd (Nasdaq: EFTY), a Hong Kong-headquartered financial services firm, today priced its initial public offering (the “Offering”) of 1,400,000 Class A ordinary shares at $4.00 per share. The Class A ordinary shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on August 8, 2025 under the ticker symbol “EFTY.”
The Company expects to receive aggregate gross proceeds of US$5.6 million from the Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 210,000 Class A ordinary shares at the public offering price, less underwriting discounts. The Offering is expected to close on or about August...